节点文献

经直肠超声对放化疗后直肠癌浸润深度判断价值探讨

The Value of Transrectal Ultrasonography in the Assessment of Invasion Depth of Rectal Cancer with Chemoradiation

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 廖盛日范智慧严昆戴莹赵爱莲顾晋苏向前陈敏华

【Author】 Liao Shengri;Fan Zhihui;Yan Kun;Key laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital&Institute;

【机构】 北京大学临床肿瘤学院北京肿瘤医院北京市肿瘤防治研究所 恶性肿瘤发病机制及转化研究教育部重点实验室超声科北京市肿瘤防治研究所 恶性肿瘤发病机制及转化研究教育部重点实验室病理科北京市肿瘤防治研究所 恶性肿瘤发病机制及转化研究教育部重点实验室外科

【摘要】 目的比较术前经直肠超声(TRUS)对未经放化疗及放化疗后直肠癌浸润深度判断的准确性,分析放化疗后TRUS在直肠癌分期中应用价值。方法病例分为2组:术前未经放化疗组179例,术前放化疗组148例,所有病例术前均行TRUS检查,并经手术切除。按直肠癌TNM分期标准进行浸润深度分期,并与手术病理结果对照。结果未经放化疗组直肠癌TRUS的准确性为78.2%(140/179),TRUS对pT1~pT4各期直肠癌灵敏性分别为83.3%(15/18)、50.0%(21/42)、88.0%(95/108)、81.8(9/11)。术前放化疗组直肠癌TRUS准确性为62.2%(92/148),对pT0~pT4各期灵敏性分别为0、12.5%(1/8)、42.9%(21/49)、87.3%(62/71)、88.9%(8/9)。TRUS对未经放化疗直肠癌浸润深度判断的准确性明显高于放化疗组(P<0.01),pT1期直肠癌未经放化疗组TRUS灵敏性明显高于放化疗组(P<0.01),而对pT2~T4各期直肠癌TRUS灵敏性两组比较无显著性差异(P>0.05)。结论放化疗后TRUS对直肠癌浸润深度判断的准确性下降,尤其对放化疗后pT0期及pT1直肠癌准确判断困难。TRUS对pT3及pT4期直肠癌判断的灵敏性较高,放化疗组与未经放化疗组比较无显著性差异。

【Abstract】 Objective To evaluate the accuracy of TRUS in the assessment of the invasion depth of rectal cancer with chemoradiation and without chemoradiation.to analyEe the clinical value of TRUS in the preoperative staging of rectal cancer with chemoradiation.Methods Patients were divided into two groups:179 patients without preoperative chemoradiation and 148 patients with preoperative chemoradiation.Patients underwent operations and TRUS preoperatively.The results of TRUS were compared with the operative and postoperatively pathological findings according to TNM classification.Results The overall accuracy of TRUS for the rectal cancer without chemoradiation was 78.2%(140/179).The sensitivity of TRUS was 83.3%(15/18)in pT1 rectal cancer,50.0%(21/42)in pT2,88.0%(95/108)in pT3,and 81.8(9/11) in pT4.The overall accuracy of TRUS for the rectal cancer with chemoradiation is62.2%(92/148).The sensitivity of TRUS in pT0 rectal cancer was 0,12.5%(1/8) in pT1,42.9%(21/49)in pT2,87.3%(62/71)in pT3,88.9%(8/9)in pT4.The overall accuracy of TRUS for the staging of rectal cancer without chemoradiation was significantly higher than that of TRUS for the cases with chemoradiation(P<0.01).The sensitivity of TRUS for pTl rectal cancer without chemoradiation was significantly higher than that of TRUS for cases with chemoradiation(P<0.01).The differences were not significant between cases with and without chemoradiation in the sensitivity of TRUS for pT2~T4 rectal cancer(P>0.05).Conclusions The accuracy of TRUS in the staging for rectal cancer with chemoradiation is less accuracy,and it is difficult to predict rectal cancer with pTO and pTl with chemoradiation correctly.The sensitivity of TRUS for pT3 and pT4 rectal cancer is relatively high,and there is no significant difference between cases with chemoradiation and without chemoradiation.

【基金】 首都医学发展科研基金(No.ZD199909);北京市卫生局科学研究项目(No.2002-1-45)
  • 【会议录名称】 《中国超声医学杂志》2011-2012年度评选优秀论文会议资料汇编
  • 【会议名称】《中国超声医学杂志》2011-2012年度评选优秀论文会议
  • 【会议时间】2013-08-23
  • 【会议地点】中国北京
  • 【分类号】R445.1;R735.37
  • 【主办单位】中国超声医学工程学会
节点文献中: 

本文链接的文献网络图示:

本文的引文网络